19-11-2026 17:40 via Drugs.com - News for Health Professionals

Broad Genomic Sequencing Improves Survival in First-Line Setting in Advanced NSCLC

THURSDAY, Nov. 19, 2026-- In the first-line, but not the second-line setting, broad-based genomic sequencing (BGS) is associated with improved progression-free (PFS) and overall survival (OS) compared with focused biomarker testing (FBT) in...
Read more »